Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Smalling

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
American Heart Journal|October 1, 1982
Beneficial effects of intracoronary thrombolysis up to eighteen hours after onset of pain in evolving myocardial infarctionR W Smalling, F Fuentes, G C Freund, et al.
Journal of the American College of Cardiology|April 1, 1990
Improved infarct-related arterial patency after high dose, weight-adjusted, rapid infusion of tissue-type plasminogen activator in myocardial infarction: results of a multicenter randomized trial of two dosage regimensR W Smalling, R Schumacher, D Morris, et al.
Journal of the American College of Cardiology|June 13, 2001
Percutaneous and surgical interventions for in-stent restenosis: long-term outcomes and effect of diabetes mellitusA Moustapha, A R Assali, S Sdringola, et al.
The American Journal of Cardiology|October 26, 2001
Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab or tirofiban)A R Assali, J Salloum, S Sdringola, et al.
The Journal of Invasive Cardiology|June 1, 2001
Percutaneous intervention in saphenous venous grafts: in-stent restenosis lesions are safer than de novo lesionsA R Assali, S Sdringola, A Moustapha, et al.
American Heart Journal|April 1, 1984
Role of coronary artery bypass surgery after intracoronary streptokinase infusion for myocardial infarctionW E Walker, R W Smalling, F Fuentes, et al.
Circulation|July 1, 1983
Sustained improvement in left ventricular function and mortality by intracoronary streptokinase administration during evolving myocardial infarctionR W Smalling, F Fuentes, M W Matthews, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 18, 2001
Risk assessment of slow or no-reflow phenomenon in aortocoronary vein graft percutaneous interventionS Sdringola, A R Assali, M Ghani, et al.
Circulation|September 1, 1996
Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II InvestigatorsC Bode, R W Smalling, G Berg, et al.
Journal of the American College of Cardiology|June 1, 1987
A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissue-type plasminogen activator (activase) in acute myocardial infarctionE J Topol, D C Morris, R W Smalling, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
American Heart Journal|October 1, 1982
Beneficial effects of intracoronary thrombolysis up to eighteen hours after onset of pain in evolving myocardial infarctionR W Smalling, F Fuentes, G C Freund, et al.
Journal of the American College of Cardiology|April 1, 1990
Improved infarct-related arterial patency after high dose, weight-adjusted, rapid infusion of tissue-type plasminogen activator in myocardial infarction: results of a multicenter randomized trial of two dosage regimensR W Smalling, R Schumacher, D Morris, et al.
Journal of the American College of Cardiology|June 13, 2001
Percutaneous and surgical interventions for in-stent restenosis: long-term outcomes and effect of diabetes mellitusA Moustapha, A R Assali, S Sdringola, et al.
The American Journal of Cardiology|October 26, 2001
Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab or tirofiban)A R Assali, J Salloum, S Sdringola, et al.
The Journal of Invasive Cardiology|June 1, 2001
Percutaneous intervention in saphenous venous grafts: in-stent restenosis lesions are safer than de novo lesionsA R Assali, S Sdringola, A Moustapha, et al.
American Heart Journal|April 1, 1984
Role of coronary artery bypass surgery after intracoronary streptokinase infusion for myocardial infarctionW E Walker, R W Smalling, F Fuentes, et al.
Circulation|July 1, 1983
Sustained improvement in left ventricular function and mortality by intracoronary streptokinase administration during evolving myocardial infarctionR W Smalling, F Fuentes, M W Matthews, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 18, 2001
Risk assessment of slow or no-reflow phenomenon in aortocoronary vein graft percutaneous interventionS Sdringola, A R Assali, M Ghani, et al.
Circulation|September 1, 1996
Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II InvestigatorsC Bode, R W Smalling, G Berg, et al.
Journal of the American College of Cardiology|June 1, 1987
A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissue-type plasminogen activator (activase) in acute myocardial infarctionE J Topol, D C Morris, R W Smalling, et al.
Pageof 10